77 research outputs found
Finalist essays from the Center for Homeland Defense and Security's First Annual Essay Competition, 2008
The Center for Homeland Defense and Security (CHDS) announces the winner and finalists
of its first annual essay contest. CHDS launched the contest last year to provide people from
around the country the opportunity to express their opinions on homeland security issues
and to suggest new ideas. The winner and four finalists were selected from eighty contest
submissions by a committee comprised of CHDS staff, faculty, and alumni. The variety of
the essay topics submitted, as well as the backgrounds of the authors, highlights the vast
scope of the impact that homeland security policies, programs, and challenges have on our
communities and professions. This year’s contestants were asked to answer the question
“What single aspect of Homeland Security has been most successful, and what single aspect
will be most critical to Homeland Security success?”Naval Posgraduate School, Center for Homeland Defense and Securit
The Vehicle, Fall 1987
Table of Contents
Sketches in the SunRodger L. Patiencepage 3
Reflecting PoolRob Montgomerypage 5
Grandpa\u27s Porcelain DollRichard E. Hallpage 6
Tintype 1837Catherine Friemannpage 6
PhotographSteven M. Beamerpage 7
Washerwoman\u27s SongBob Zordanipage 8
Scrambled Eggs for D.O.Lynne A. Rafoolpage 8
my mother would sayMonica Grothpage 9
Retired by His ChildrenDan Von Holtenpage 10
I am the oldestMonica Grothpage 11
Ice on WheatRob Montgomerypage 12
The Nature of the RoseTroy Mayfieldpage 12
Past NebraskaDan Hornbostelpage 13
Five Minute Jamaican VacationChristy Dunphypage 14
PhotographSteven M. Beamerpage 14
The Angry PoemChristy Dunphypage 15
Road UnfamiliarChristy Dunphypage 15
raised voicesMonica Grothpage 16
Old Ladies & MiniskirtsKara Shannonpage 17
FreakspeakBob Zordanipage 18
PortraitDan Von Holtenpage 18
Mobile VacuumKathleen L. Fairfieldpage 19
Rev. Fermus DickSteve Hagemannpage 20
PhotographSteven M. Beamerpage 21
What\u27s the Name of That Flower?Richard Jesse Davispage 22
RequestChristy Dunphypage 23
SketchPaul Seabaughpage 24
ExperiencedMarilyn Wilsonpage 26
Leaving: Two ViewsTina Phillipspage 27
AntaeusDan Von Holtenpage 28
Misogyny at 19J. D. Finfrockpage 29
A Mental CrippleSteve Hagemannpage 32
AssociationsRhonda Ealypage 33
Banana BreadGail Bowerpage 34
Bill and JackBradford B. Autenpage 35
After Image No. 2Rob Montgomerypage 35
VrrooomBeth Goodmanpage 36
Mr. Modern LoverMolly Maddenpage 36
TravelogueRodger L. Patiencepage 37
Down the HighwayJoan Sebastianpage 38
A Retread HeavenRob Montgomerypage 41
StuporDan Von Holtenpage 42
Love Poem After a Seizure in Your BedBob Zordanipage 43
PalsyChristy Dunphypage 44
Interview with Mr. MatthewsBob Zordanipage 45
Chasing Down Hot Air Balloons on a Sunday MorningRob Montgomerypage 48https://thekeep.eiu.edu/vehicle/1049/thumbnail.jp
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016) : part two
Background
The immunological escape of tumors represents one of the main ob- stacles to the treatment of malignancies. The blockade of PD-1 or CTLA-4 receptors represented a milestone in the history of immunotherapy. However, immune checkpoint inhibitors seem to be effective in specific cohorts of patients. It has been proposed that their efficacy relies on the presence of an immunological response. Thus, we hypothesized that disruption of the PD-L1/PD-1 axis would synergize with our oncolytic vaccine platform PeptiCRAd.
Methods
We used murine B16OVA in vivo tumor models and flow cytometry analysis to investigate the immunological background.
Results
First, we found that high-burden B16OVA tumors were refractory to combination immunotherapy. However, with a more aggressive schedule, tumors with a lower burden were more susceptible to the combination of PeptiCRAd and PD-L1 blockade. The therapy signifi- cantly increased the median survival of mice (Fig. 7). Interestingly, the reduced growth of contralaterally injected B16F10 cells sug- gested the presence of a long lasting immunological memory also against non-targeted antigens. Concerning the functional state of tumor infiltrating lymphocytes (TILs), we found that all the immune therapies would enhance the percentage of activated (PD-1pos TIM- 3neg) T lymphocytes and reduce the amount of exhausted (PD-1pos TIM-3pos) cells compared to placebo. As expected, we found that PeptiCRAd monotherapy could increase the number of antigen spe- cific CD8+ T cells compared to other treatments. However, only the combination with PD-L1 blockade could significantly increase the ra- tio between activated and exhausted pentamer positive cells (p= 0.0058), suggesting that by disrupting the PD-1/PD-L1 axis we could decrease the amount of dysfunctional antigen specific T cells. We ob- served that the anatomical location deeply influenced the state of CD4+ and CD8+ T lymphocytes. In fact, TIM-3 expression was in- creased by 2 fold on TILs compared to splenic and lymphoid T cells. In the CD8+ compartment, the expression of PD-1 on the surface seemed to be restricted to the tumor micro-environment, while CD4 + T cells had a high expression of PD-1 also in lymphoid organs. Interestingly, we found that the levels of PD-1 were significantly higher on CD8+ T cells than on CD4+ T cells into the tumor micro- environment (p < 0.0001).
Conclusions
In conclusion, we demonstrated that the efficacy of immune check- point inhibitors might be strongly enhanced by their combination with cancer vaccines. PeptiCRAd was able to increase the number of antigen-specific T cells and PD-L1 blockade prevented their exhaus- tion, resulting in long-lasting immunological memory and increased median survival
Tick-Borne Diseases of Humans
Comprehensive information on the biology, ecology, and clinical aspects of these diseases.• Presents state-of-the-art information on disease epidemiology, transmission, and ecology. • Integrates divergent information relevant to the full spectrum of tick-borne diseases, incorporating tick biology and identification, distribution of the diseases ticks transmit, and various strategies for tick control. • Reviews the clinical approach to a patient with a possible tick-borne affliction. • Features in-depth profiles of specific diseases, including information on disease history, biology, epidemiology, ecology, transmission, clinical manifestations, diagnosis, treatment and prevention. • Examines the geographical distribution of tick-borne diseases and their vectors.
(from amazon.com)https://digitalcommons.odu.edu/biology_books/1001/thumbnail.jp
UCRL-93431 PREPRINT A Ground Reaction Curve Based Upon Block Theory
September 1985 ~rjT'n 0'-"ii's rj:i^:;;r is rc.RT;
- …